Evidence map›Paper›PMID 37545538›Full record

ArticleFrontiers in immunology2023

Immunoprecipitation methods impact the peptide repertoire in immunopeptidomics.

Marcel Wacker, Jens Bauer, Laura Wessling, Marissa Dubbelaar, Annika Nelde, Hans-Georg Rammensee, Juliane S Walz

Abstract read
In one paragraph

Article in Frontiers in immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Molecular origin, discovery, validation and application of neoantigens.Asian journal of pharmaceutical sciences · 2026
    Review
  5. Immunoproteomics: The Evolution from Classical Methods to Emerging Techniques.Methods in molecular biology (Clifton, N.J.) · 2026
    Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Marcel WackerDepartment of Peptide-based Immunotherapy, University and University Hospital Tübingen, Tübingen, Germany.
Jens BauerDepartment of Peptide-based Immunotherapy, University and University Hospital Tübingen, Tübingen, Germany.
Laura WesslingInstitute for Cell Biology, Department of Immunology, University of Tübingen, Tübingen, Germany.
Marissa DubbelaarDepartment of Peptide-based Immunotherapy, University and University Hospital Tübingen, Tübingen, Germany.
Annika NeldeDepartment of Peptide-based Immunotherapy, University and University Hospital Tübingen, Tübingen, Germany.
Hans-Georg RammenseeInstitute for Cell Biology, Department of Immunology, University of Tübingen, Tübingen, Germany.
Juliane S WalzDepartment of Peptide-based Immunotherapy, University and University Hospital Tübingen, Tübingen, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Mass spectrometry-based immunopeptidomics is the only unbiased method to identify naturally presented HLA ligands, which is an indispensable prerequisite for characterizing novel tumor antigens for immunotherapeutic approaches. In recent years, improvements based on devices and methodology have been made to optimize sensitivity and throughput in immunopeptidomics. However, developments in ligand isolation, mass spectrometric analysis, and subsequent data processing can have a marked impact on the quality and quantity of immunopeptidomics data. Methods: In this work, we compared the immunopeptidome composition in terms of peptide yields, spectra quality, hydrophobicity, retention time, and immunogenicity of two established immunoprecipitation methods (column-based and 96-well-based) using cell lines as well as primary solid and hematological tumor samples. Results: Although, we identified comparable overall peptide yields, large proportions of method-exclusive peptides were detected with significantly higher hydrophobicity for the column-based method with potential implications for the identification of immunogenic tumor antigens. We showed that column preparation does not lose hydrophilic peptides in the hydrophilic washing step. In contrast, an additional 50% acetonitrile elution could partially regain lost hydrophobic peptides during 96-well preparation, suggesting a reduction of the bias towards the column-based method but not completely equalizing it. Discussion: Together, this work showed how different immunoprecipitation methods and their adaptions can impact the peptide repertoire of immunopeptidomic analysis and therefore the identification of potential tumor-associated antigens.

Indexed as

NeoplasmsPeptidesAntigens, NeoplasmHumansImmunoprecipitationMass SpectrometryAntigens, NeoplasmPeptidesHLA peptideshydrophobicityimmunogenicityimmunopeptidomicsimmunoprecipitationimmunotherapiesmass spectrometry

Identifiers

PMID37545538
PMCPMC10400765

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.